Zuojiong Gong, [email protected] These authors share first authorship This article was submitted to Metabolomics, a section of the journal Frontiers in Molecular Biosciences Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
The study included a survey with 1,955 useable observations including 495 people who were currently taking a GLP-1, 468 who had previously taken one, 492 people who were planning to take one, and 500 people who were neither taking one nor planning to take one
It has emerged as a promising candidate for addressing neurological disorders like Alzheimer's and Parkinson's disease, combating inflammation, and even managing lingering symptoms of long COVID
9(5): p
However, more research is needed to fully understand and substantiate these benefits
Total glutathione, measuring both reduced glutathione (GSH) and oxidised glutathione (GSSG) was assessed in metformin treated HCT116 and SW837 cells by luminescent assay
